COX-2 Expression in Breast Cancer
Author Information
Author(s): Glover J A, Hughes C M, Cantwell M M, Murray L J
Primary Institution: Queen's University Belfast
Hypothesis
The study aims to evaluate the frequency of COX-2 expression in various stages of breast pathology.
Conclusion
COX-2 expression is common in both ductal carcinoma in situ and invasive breast cancer, suggesting its role in early breast cancer development.
Supporting Evidence
- COX-2 expression was found in 53% of DCIS samples.
- COX-2 expression was found in 42% of invasive breast cancer samples.
- The study included a total of 12 studies for invasive breast cancer analysis.
Takeaway
This study looked at how often a specific protein called COX-2 shows up in different types of breast cancer, finding it appears a lot in both early and advanced stages.
Methodology
The study conducted a systematic review and meta-analysis of primary studies examining COX-2 expression using immunohistochemistry.
Potential Biases
High heterogeneity among studies may affect the reliability of the findings.
Limitations
Few studies were available for normal breast epithelium, DCIS-adjoining invasive cancer, and microinvasive carcinoma, limiting robust estimates.
Participant Demographics
The studies included samples from various populations, but specific demographic details were not provided.
Statistical Information
P-Value
0.04
Confidence Interval
95% CI, 44–61 for DCIS; 95% CI, 36–49 for invasive breast cancer
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website